View abstracts of studies supported by our research funding.

 
Select Filters
Apply Filters

Genetic and environmental contributions to longitudinal tau trajectories

Anouk den Baraber, Ph.D.
Amsterdam, Netherlands
2024

Understanding the Negative Impact of APOE4 on Neural Responses to Estrogens

Karyn Frick, Ph.D.
Milwaukee, WI - United States
2024

Replacement of Peripheral APOE4 with APOE2: Effects on AD Pathology

Lance Johnson, Ph.D.
Lexington, KY - United States
2024

PET imaging of neuroinflammation in dementia with Lewy bodies

Min-Jeong Kim, M.D., Ph.D.
Stony Brook, NY - United States
2024

APOE Modifiers of Human Microglia Biology in Alzheimer’s disease

Renzo Mancuso, Ph.D.
Ghent, Belgium
2024

Supplement to Novel mouse models to study the biology of APOE variant risk

Michael Sasner, Ph.D.
Bar Harbor, ME - United States
2024

Identification of Modifiers of APOEe4 Toxicity

Beth Stevens, Ph.D.
Boston, MA - United States
2024

Development of chemical exchange saturation transfer MRI for dementia with Lewy bodies

Phillip Zhe Sun, Ph.D.
Altanta, GA - United States
2024

Uncovering miRNA-mediated Adipose-Brain Crosstalk in Alzheimer’s Disease

Marcelo A. Mori, Ph.D.
Campinas, Brazil
2023

Association Between Longitudinal Changes in Plasma GFAP and AD Progression

Sarah Abbas, Ph.D.
Pittsburgh, PA - United States
2023

Vascular cognitive impairment in diabetes: mechanisms and intervention

Kareem Abdelsaid, Ph.D.
Charleston, SC - United States
2023

Identifying ethnic disparities in AD risk and blood biomarkers in Israel

Maison Abu Raya, M.D.
Haifa, Israel
2023

Inclusive ADRD Clinical Trials: Screening, Enrolling Latino Participants

G. Adriana Perez, Ph.D.
Philadelphia, PA - United States
2023

Identification of retromer modifiers by arrayed genome-wide perturbation

Adriano Aguzzi, M.D.
Zurich, Switzerland
2023

Pyroptosis-induced gut-brain disruption after Stroke in Alzheimer’s disease

Nadine Ahmed Kerr, Ph.D.
Miami, FL - United States
2023

Restoring Excitation-Inhibition Balance in Alzheimer’s Disease Mouse Models

Moustafa Algamal, Ph.D.
Boston, MA - United States
2023

Undiagnosed Dementia in Hospitals: Prevalence, Risk Factors, and Outcomes

Márlon Aliberti, M.D., Ph.D.
Sao Paulo, Brazil
2023

Identifying Astrocyte-Mediated Vasomotion Underlying AD Pathogenesis

Xiaoqing Alice Zhou, Ph.D.
Boston, MA - United States
2023

Uncovering the Role of SORL1 as a Key Regulator of AD Endosomal Pathology

Brooke Alisen DeRosa, Ph.D.
Miami, FL - United States
2023

Influence of the Microenvironment on the Turnover of Fluid Biomarkers

Tatiana Alvarez Giovannucci, Ph.D.
London, United Kingdom
2023

Dementia training for primary health care workers in Ethiopia

Mohammed Anbessie, M.D.
Addis Ababa, Ethiopia
2023

Interrogating Metabolic Dysregulation in Neurodegeneration Using Organoids

Madeline Andrews, Ph.D.
Tempe, AZ - United States
2023

Kv7 K+ channels, BACE1, APP, and Alzheimer's disease-related epilepsy

Fabio Antonio Borges Vigil, Ph.D.
San Antonio, TX - United States
2023

Multi-Omics Characterization of a Diverse Population in the South of Brazil

Marco Antônio De Bastiani, Ph.D.
PORTO ALEGRE, Brazil
2023

Targeted Network Attack in Assessing Brain Resilience

Georgette Argiris, Ph.D.
New York, NY - United States
2023

The Role of Astrocytic Tau Deposition onto Synaptic and Memory Dysfunction

Eleni-Kostania Argyrousi, Ph.D.
New York, NY - United States
2023

Assessing Meaningful Engagement in Advanced Dementia (MEAD)

Arlene Astell, Ph.D.
Toronto, Canada
2023

A CRISPR-Based Therapeutic for Alzheimer's disease

Brent Aulston, Ph.D.
La Jolla, CA - United States
2023

A Clinical Quality Registry for Dementia in Ethiopia (CQRD Ethiopia)

Biniyam Ayele, M.D.
Addis Ababa, Ethiopia
2023

Hypothalamic Nuclei and the Spatiotemporal Evolution of Alzheimer’s disease

Marion Baillet, Ph.D.
Liege, Belgium
2023

1 2 3 4 5 6 7 8 9 10... >|